13 July 2023

Analgesics Pain Public Health

What does the OPAL study really mean?

1 June 2023

Analgesics Clinical Medications

Burnt out and overworked GPs more likely to prescribe opioids

16 March 2023

Analgesics Public Health

RACGP doubles down on paracetamol pack size

23 June 2022

Analgesics Mental Health Rheumatoid Arthritis

Mental illness leads chronic disease pack

16 June 2022

Analgesics COVID-19

Doctors at risk of green-nail syndrome

5 May 2022

Analgesics Gout

Alopecia hope in common arthritis drug

2 September 2021

Analgesics Conditions Scleroderma

New hub for patients living with psoriatic arthritis

19 August 2021

Analgesics

Diagnosing familial Mediterranean fever

12 August 2021

Analgesics COVID-19

Growing clamour for booster shots in immunocompromised patients

5 August 2021

Analgesics

Gold rush! Rheumatology meets the Olympics

24 June 2021

Analgesics Biologics

Australian posters at EULAR

17 June 2021

Analgesics

Social impact of living with musculoskeletal conditions: survey

29 April 2021

Analgesics Technology

Teen Talk – connect with others who ‘get it’

15 December 2020

Analgesics Conditions Spondyloarthritis

Vagus nerve stimulation for RA symptom control

3 December 2020

Analgesics Conditions Spondyloarthritis

Battle of the monotherapies: etanercept vs methotrexate

3 December 2020

Analgesics Conditions Lupus

Ixekizumab PBS-subsidised for AS